Ivette J. Suárez-Arroyo
About
In The Last Decade
Ivette J. Suárez-Arroyo
19 papers receiving 320 citations
Peers
Comparison fields: 5 of 63
- Pharmacology 189
- Molecular Biology 150
- Pharmacology 97
- Complementary and alternative medicine 65
- Oncology 53
Countries citing papers authored by Ivette J. Suárez-Arroyo
This map shows the geographic impact of Ivette J. Suárez-Arroyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivette J. Suárez-Arroyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivette J. Suárez-Arroyo more than expected).
Fields of papers citing papers by Ivette J. Suárez-Arroyo
This network shows the impact of papers produced by Ivette J. Suárez-Arroyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivette J. Suárez-Arroyo. The network helps show where Ivette J. Suárez-Arroyo may publish in the future.
Co-authorship network of co-authors of Ivette J. Suárez-Arroyo
This figure shows the co-authorship network connecting the top 25 collaborators of Ivette J. Suárez-Arroyo. A scholar is included among the top collaborators of Ivette J. Suárez-Arroyo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivette J. Suárez-Arroyo. Ivette J. Suárez-Arroyo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | Ganoderma lucidum enhances carboplatin chemotherapy effect by inhibiting the DNA damage response pathway and stemness. | 4 |
| 4 | 7 | |
| 5 | 18 | |
| 6 | 1 | |
| 7 | 13 | |
| 8 | 10 | |
| 9 | 1 | |
| 10 | 75 | |
| 11 | 23 | |
| 12 | 1 | |
| 13 | 24 | |
| 14 | 28 | |
| 15 | The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease. | 27 |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 86 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.